David
Pidduck,
President & CEO
(Corporation)
Learn more...
Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.
Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.
Results below are sorted by posted date, beginning with the most recent.
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Suzy McDonald,
Assistant Deputy Minister
| Opioid Response Team
|
Health Canada (HC)
Subject Matter of the communication:
Health,
Industry,
Justice and Law Enforcement,
Science and Technology
Communication date:
2017-11-02
Posted date:
2017-12-15
Communication number:
5031-411562
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Kevin Sorenson,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
Justice and Law Enforcement,
Science and Technology,
Aboriginal Affairs
Communication date:
2016-11-15
Posted date:
2016-12-15
Communication number:
5031-388169
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Ralph Goodale,
Minister
|
Public Safety Canada (PS)
-
Marci Surkes,
Chief of Staff
| Office of the Minister
|
Public Safety Canada (PS)
-
David Hurl,
Director of Policy
| Office of the Minister
|
Public Safety Canada (PS)
Subject Matter of the communication:
Health,
Industry,
Justice and Law Enforcement,
National Security/Security,
Science and Technology
Communication date:
2016-10-05
Posted date:
2016-11-15
Communication number:
5031-384578
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Vernon White,
Senator
|
Senate of Canada
Subject Matter of the communication:
Health,
Industry,
Justice and Law Enforcement,
National Security/Security,
Science and Technology
Communication date:
2016-10-05
Posted date:
2016-11-15
Communication number:
5031-384577
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Kelvin Ogilvie,
Senator
|
Senate of Canada
Subject Matter of the communication:
Health,
Industry,
Justice and Law Enforcement,
Science and Technology
Communication date:
2016-10-04
Posted date:
2016-11-15
Communication number:
5031-384444
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Kevin Sorenson,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
Justice and Law Enforcement,
Science and Technology
Communication date:
2016-09-22
Posted date:
2016-10-15
Communication number:
5031-384217
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Colin Carrie,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Industry,
Justice and Law Enforcement,
Science and Technology
Communication date:
2016-09-09
Posted date:
2016-10-15
Communication number:
5031-383210
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Hilary Geller,
Assistant Deputy Minister
| Healthy Environments and Community Safety Branch
|
Health Canada (HC)
Subject Matter of the communication:
Health,
Industry,
Justice and Law Enforcement,
Science and Technology
Communication date:
2016-09-08
Posted date:
2016-10-15
Communication number:
5031-383094
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Jennifer O'Connell,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Industry,
Justice and Law Enforcement,
Science and Technology
Communication date:
2016-09-07
Posted date:
2016-10-15
Communication number:
5031-383093
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Peter Harder,
Senator
|
Senate of Canada
Subject Matter of the communication:
Health,
Industry,
Justice and Law Enforcement,
Science and Technology
Communication date:
2016-08-30
Posted date:
2016-09-15
Communication number:
5031-382951
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Colin Carrie,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Industry,
Justice and Law Enforcement,
International Trade
Communication date:
2016-06-20
Posted date:
2016-07-15
Communication number:
5031-380219
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Wayne Easter,
Member of Parliament
|
House of Commons
-
Gordon Brown,
Member of Parliament
|
House of Commons
-
Brian Masse,
Member of Parliament
|
House of Commons
-
Phil McColeman,
Member of Parliament
|
House of Commons
-
David McGuinty,
Member of Parliament
|
House of Commons
-
Sherry Romanado,
Member of Parliament
|
House of Commons
-
Judy Sgro,
Member of Parliament
|
House of Commons
-
Francesco Sorbara,
Member of Parliament
|
House of Commons
-
Brad Trost,
Member of Parliament
|
House of Commons
-
Yvonne Jones,
Member of Parliament
|
House of Commons
-
David Tilson,
Member of Parliament
|
House of Commons
-
Wilfred Moore,
Senator
|
Senate of Canada
-
Michael MacDonald,
Senator
|
Senate of Canada
Subject Matter of the communication:
Health,
Industry,
Justice and Law Enforcement,
Science and Technology
Communication date:
2016-05-11
Posted date:
2016-06-15
Communication number:
5031-377667
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Wayne Easter,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Industry,
Justice and Law Enforcement,
National Security/Security,
Science and Technology
Communication date:
2016-05-04
Posted date:
2016-06-15
Communication number:
5031-375690
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Hilary Geller,
Assistant Deputy Minister
| Healthy Environments and Consumer Safety
|
Health Canada (HC)
Subject Matter of the communication:
Health,
Industry,
Justice and Law Enforcement,
Science and Technology
Communication date:
2016-05-04
Posted date:
2016-06-15
Communication number:
5031-375688
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Colin Carrie,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
Justice and Law Enforcement,
Science and Technology
Communication date:
2016-04-21
Posted date:
2016-05-16
Communication number:
5031-375196
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Vernon White,
Senator
|
Senate of Canada
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
Justice and Law Enforcement,
Science and Technology
Communication date:
2016-04-21
Posted date:
2016-05-16
Communication number:
5031-375195
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Giovanni (John) Prato,
Consul General of Canada in New York
|
Global Affairs Canada (GAC)
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
Justice and Law Enforcement,
International Trade,
Science and Technology
Communication date:
2016-04-14
Posted date:
2016-05-16
Communication number:
5031-374808
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Len Webber,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
Justice and Law Enforcement,
Science and Technology
Communication date:
2016-04-12
Posted date:
2016-05-16
Communication number:
5031-374172
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Rob Oliphant,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
Justice and Law Enforcement,
National Security/Security,
Science and Technology
Communication date:
2016-04-07
Posted date:
2016-05-16
Communication number:
5031-373754
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Celina Caesar-Chavannes,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
Science and Technology,
Aboriginal Affairs
Communication date:
2016-03-21
Posted date:
2016-04-15
Communication number:
5031-373187
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Ron McKinnon,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
Science and Technology
Communication date:
2016-03-21
Posted date:
2016-04-15
Communication number:
5031-373167
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Greg Fergus,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
Science and Technology
Communication date:
2016-03-17
Posted date:
2016-04-15
Communication number:
5031-373040
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Steven MacKinnon,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Intellectual Property,
Justice and Law Enforcement,
Science and Technology
Communication date:
2016-03-11
Posted date:
2016-04-15
Communication number:
5031-373039
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Jennifer O'Connell,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Industry,
Justice and Law Enforcement,
International Trade,
Science and Technology
Communication date:
2016-03-08
Posted date:
2016-04-15
Communication number:
5031-370947
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Caroline Pitfield,
Director of Policy
| Office of the Minister
|
Health Canada (HC)
-
Kathryn Nowers,
Policy Advisor
| Office of the Minister
|
Health Canada (HC)
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
Justice and Law Enforcement,
Science and Technology
Communication date:
2016-03-04
Posted date:
2016-04-15
Communication number:
5031-370636
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Pablo Rodriguez,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
Science and Technology
Communication date:
2016-02-23
Posted date:
2016-03-15
Communication number:
5031-370152
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Hilary Geller,
Assistant Deputy Minister
| Healthy Environments and Consumer Safety Branch
|
Health Canada (HC)
Subject Matter of the communication:
Health,
Industry,
Justice and Law Enforcement,
Science and Technology
Communication date:
2016-02-18
Posted date:
2016-03-15
Communication number:
5031-369916
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
John Burnett,
Director of Policy
| Office of the Minister of Science
|
Innovation, Science and Economic Development Canada (ISED)
-
Stephanie Muccilli,
Policy Advisor
| Office of the Minister of Science
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Industry,
Justice and Law Enforcement,
Science and Technology,
Aboriginal Affairs
Communication date:
2016-02-10
Posted date:
2016-03-15
Communication number:
5031-368697
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Andrew Leslie,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Industry,
Justice and Law Enforcement,
Science and Technology
Communication date:
2016-02-08
Posted date:
2016-03-15
Communication number:
5031-368587
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Ben Lobb,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Industry,
Justice and Law Enforcement,
Science and Technology
Communication date:
2016-02-05
Posted date:
2016-03-15
Communication number:
5031-368303
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Dr. Kellie Leitch,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Industry,
Justice and Law Enforcement,
Science and Technology
Communication date:
2016-02-02
Posted date:
2016-03-15
Communication number:
5031-367987
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Don Davies,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Industry,
Justice and Law Enforcement,
Science and Technology
Communication date:
2016-02-02
Posted date:
2016-03-15
Communication number:
5031-367986
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Garry Keller,
Chief of Staff
| Office of the Leader of the Official Opposition
|
House of Commons
Subject Matter of the communication:
Health,
Industry,
Justice and Law Enforcement,
Science and Technology
Communication date:
2016-01-29
Posted date:
2016-02-03
Communication number:
5031-367985
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Hedy Fry,
Memer of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Intellectual Property,
Justice and Law Enforcement,
Science and Technology
Communication date:
2015-12-02
Posted date:
2016-01-15
Communication number:
5031-365011
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
James Maunder,
Chief of Staff
| Office of the Minister
|
Industry Canada
Subject Matter of the communication:
Health,
Industry,
Justice and Law Enforcement,
Science and Technology
Communication date:
2015-08-13
Posted date:
2015-09-15
Communication number:
5031-359814
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Sean Speer,
Special Advisor
|
Prime Minister's Office (PMO)
Subject Matter of the communication:
Health,
Industry,
Justice and Law Enforcement
Communication date:
2015-07-10
Posted date:
2015-08-15
Communication number:
5031-358431
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Ben Lobb,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Industry,
Justice and Law Enforcement
Communication date:
2015-04-30
Posted date:
2015-05-15
Communication number:
5031-353685
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Simon Kennedy,
Deputy Minister
|
Health Canada (HC)
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
Justice and Law Enforcement
Communication date:
2015-04-17
Posted date:
2015-05-15
Communication number:
5031-353736
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
John Knubley,
Deputy Minister
|
Industry Canada
-
Paul Halucha,
Associate Assistant Deputy Minister
|
Industry Canada
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
International Trade,
Science and Technology
Communication date:
2015-04-15
Posted date:
2015-05-15
Communication number:
5031-353731
(amended from
5031-353684)
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
John Weston,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Industry,
Justice and Law Enforcement
Communication date:
2015-03-23
Posted date:
2015-04-15
Communication number:
5031-350999
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
David Belous,
Manager, Stakeholder Relations & Outreach
|
Prime Minister's Office (PMO)
Subject Matter of the communication:
Health
Communication date:
2014-05-14
Posted date:
2014-06-16
Communication number:
5031-328074
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Jeremy Hunt,
Director, Stakeholder Relations and Outreach
|
Prime Minister's Office (PMO)
Subject Matter of the communication:
Health
Communication date:
2014-04-14
Posted date:
2014-05-15
Communication number:
5031-322780
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Paul Glover,
Associate Deputy Minister
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2014-02-13
Posted date:
2014-03-15
Communication number:
5031-317829
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Anne Lamar,
Associate Assistant Deputy Minister
| Health Products and Food Branch
|
Health Canada (HC)
-
Hilary Geller,
Assistant Deputy Minister
| Health Environments and Consumer Safety Branch
|
Health Canada (HC)
-
Supriya Sharma,
Senior Medical Advisor
| Health Products and Food Branch
|
Health Canada (HC)
-
Barbara Sabourin,
Director General
| Therapeutic Products Directorate
|
Health Canada (HC)
-
Barbara Moran,
Director, Prescription Drug Abuse Lead
| CONTROLLED SUBSTANCES AND TOBACCO DIRECTORATE
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2013-12-03
Posted date:
2014-01-15
Communication number:
5031-311203
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Eve Adams,
Parliamentary Secretary, Health
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2013-12-03
Posted date:
2014-01-15
Communication number:
5031-311201
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Laure Hawn,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2013-12-03
Posted date:
2014-01-15
Communication number:
5031-311200
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Paul Glover,
Associate Deputy Minister
|
Health Canada (HC)
-
Kathryn McDade,
Assistant Deputy Minister
| HPFB
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2013-09-04
Posted date:
2013-09-09
Communication number:
5031-289633
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Paul Glover,
Assistant Deputy Minister
| Health Products and Food Branch
|
Health Canada (HC)
Subject Matter of the communication:
Health,
Intellectual Property
Communication date:
2013-05-22
Posted date:
2013-05-23
Communication number:
5031-274509
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Chris Alexander,
Member of Parliament
| Ajax-Pickering
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2013-04-03
Posted date:
2013-05-15
Communication number:
5031-267229
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Mark Schaan,
Director
| Pharmaceutical Sector Directorate
|
Industry Canada
Subject Matter of the communication:
Health,
Industry
Communication date:
2013-03-07
Posted date:
2013-03-15
Communication number:
5031-264272
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Corneliu Chisu,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2013-02-20
Posted date:
2013-03-15
Communication number:
5031-261729
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
John Weston,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2012-10-02
Posted date:
2012-11-15
Communication number:
5031-242249
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Colin Carrie,
Parliamentary Secretary to the Minister of Health
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2012-08-23
Posted date:
2012-09-15
Communication number:
5031-234911
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Chris Alexander,
Member of Parliament, Ajax-Pickering
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2012-08-21
Posted date:
2012-09-15
Communication number:
5031-234910
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Corneliu Chisu,
Member of Parliament, Pickering-Scarborough East
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2012-08-20
Posted date:
2012-09-15
Communication number:
5031-234909
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Graham Howell,
Policy Advisor
| Office of the Minister of Health
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2010-06-02
Posted date:
2010-06-29
Communication number:
5031-151238
View associated registration
-
PURDUE PHARMA
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Meena Ballantyne,
Assistant Deputy Minister
| Health Products and Food Branch
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2010-06-01
Posted date:
2010-06-29
Communication number:
5031-151237
View associated registration